Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon?

15 Apr 2021

Abstract excerpt

The detection of cancer at an early stage while it is curable by surgical resection is widely believed to be one of the most effective strategies for reducing cancer mortality. Hence, the intense interests in the development of a simple pan-cancer screening test. Lack of sensitivity and specificity when combined with the low prevalence of most types of cancer types in the general population limit the use of most...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33856748
DOI: 10.1515/cclm-2021-0171

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon?PMID 33856748Read ↗

ctDNA as a Cancer Biomarker: A Broad OverviewSemantic proximity Read ↗

ctDNA as a cancer biomarker: A broad overview.Semantic proximity Read ↗

Circulating Tumor DNA as Biomarkers for Cancer DetectionSemantic proximity Read ↗

Circulating tumor DNA: current challenges for clinical utility.Semantic proximity Read ↗

Methylated circulating tumor DNA in blood: power in cancer prognosis and responseSemantic proximity Read ↗

Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis.Semantic proximity Read ↗

"Liquid biopsy"-ctDNA detection with great potential and challenges.Semantic proximity Read ↗

Circulating DNA in solid organ cancers-analysis and clinical application.Semantic proximity Read ↗

[Circulating Tumor DNA in Blood and Its Utilization as a Potential Biomarker for Cancer].Semantic proximity Read ↗

Circulating Tumor DNA Allele Fraction: A Candidate Biological Signal for Multicancer Early Detection Tests to Assess the Clinical Significance of Cancers.Semantic proximity Read ↗

Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?Semantic proximity Read ↗

Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.